'김갑성' 기자의 전체기사
-
Amorepacific Group Marks 80th Anniversary: Unveils New Visio…
- Aims to achieve 70% in overseas sales and rank among the global top three in premium skincare- Declares mid- to long-term strategy to become a global leader in beauty & wellness SEOUL, South Korea, Sept. 9, 2025 -- The Amorepacific group announced a new leap forward to mark its 80th anniversary. At its anniversary ceremony held on September 4, the company unveiled the goal of KRW 15 trillion in group sales by 2035, alongside its mid- to long-term vision and strategies to become a global leader in beauty and wellness. Experience the full interactive Multichannel N
- 김갑성 기자
- 2025-09-09 09:00
-
Leidos Australia launches into Australia-Pacific maritime au…
MELBOURNE, Sept. 8, 2025 -- Leidos has commenced the Australian build of Sea Archer, a next-generation small uncrewed surface vessel (USV). This marks a major step forward in bringing Leidos' proven autonomous technology and maritime systems portfolio to the Indo-Pacific region while supporting AUKUS objectives and the Australian Defence Force's mission needs. The move into local manufacturing of autonomous vessels fast-tracks proven U.S. capability to Australia, harnessing Leidos' 50-year heritage with the U.S. Navy and its record of more than 120,000 fully autonomous nautical
- 김갑성 기자
- 2025-09-09 06:00
-
서텍스, SIR-Spheres® Y-90 수지 미세구체, CE 마크 확대 승인 획득
적응증 확대로 유럽 및 CE 마크 적용 지역에서 간암 치료 접근성 향상 워번, 매사추세츠, 2025년 9월 9일 -- 최소 침습 중재적 종양학 솔루션 분야의 선도 기업인 서텍스 메디컬(Sirtex Medical, 이하 '서텍스')이 9월 8일 간암 환자 치료를 위한 SIR-Spheres® Y-90 수지 미세구체에 대해 CE 마크 확대 승인을 받았다고 발표했다. 이번 승인 확대로 원발성 간암뿐만 아니라 이차성 간 전이 환자도 치료 대상에 포함되어, 이미 확립된 표적 치료를 받을 수 있는 환자 범위가 넓어졌다. 매트 슈미트(Matt Schmidt) 서텍스 메디컬 최고경영자(CEO)는 "이번 성과는 단순한 규제 승인을 넘어, 가장 힘든 암 진단에 직면한 환자들에게 희망과 선택권을 되돌려주는 것"이라며, "SIR-Spheres® 접근성을 확대함으로써 더 많은 환자가 가장 필요할 때 잘 견디는 표적 치료 혜택을 받을 수 있도록 보장한다"라고 말했다. 선택적 내부 방사선 치료(SIRT)로 알려진 방사선색전술은 간 동맥을 통해 이트륨-90을 종양에 직접 전달해, 고용량
- 김갑성 기자
- 2025-09-09 05:31
-
Aechelon and Partners Niantic Spatial, ICEYE, BlackSky and Dis…
Pioneering the Next Era of Live Synthetic Reality—Empowering Global, All-Sensor AI Training Across All Conditions for Human Readiness and Autonomous Systems SOUTH SAN FRANCISCO, Calif., Sept. 9, 2025 -- Aechelon Technology, a global defense leader in geospatial simulation technology and human/machine AI training systems today announced 'Project Orbion' together with its partners. Project Orbion is a groundbreaking new initiative that will integrate best-of-class technology solutions to create a live Digital Twin of the Earth. All of this is complete with accurate physics, real-
- 김갑성 기자
- 2025-09-09 05:20
-
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y…
Broadened indication increases access to liver cancer treatment across Europe and CE-marked territories. WOBURN, Mass., Sept. 8, 2025 -- Sirtex Medical ("Sirtex"), a leading manufacturer of minimally invasive interventional oncology solutions, today announced that it has received an expanded CE Mark approval for SIR-Spheres® Y-90 resin microspheres for the treatment of patients with liver cancer. With this expansion, eligibility now covers both primary and secondary liver metastases, increasing patient access to a well-established, targeted therapy. "T
- 김갑성 기자
- 2025-09-08 21:00
-
Nobel Laureate Headlines Global Discussion in Cell & Gene…
PISCATAWAY, N.J., Sept. 8, 2025 -- Cell and gene therapies (CGT) are advancing rapidly and are reshaping the future of medicine. From CRISPR-based genome editing to new applications of in vivo and ex vivo cell therapies, scientific breakthroughs are increasingly moving from the laboratory into clinical practice. At the same time, global investment and innovation in the field are accelerating, positioning CGT as one of the fastest-growing areas in life sciences. One of the greatest challenges for the industry lies in translating these advances into lasting patient benefits and sustainab
- 김갑성 기자
- 2025-09-08 20:49
-
SpaceGut's Precision AI System for Gut Testing Achieves Up to…
KUALA LUMPUR, Malaysia, Sept. 8, 2025 -- SpaceGut, Malaysia's first AI-powered at-home Gut Microbiome Test Kit, has paved the way for users to take control of their digestive wellness and conditions such as Irritable Bowel Syndrome (IBS) from home. In the 10 months since it was launched, its breakthrough AI-powered gut health testing has been used by more than 500 individuals to extract tailored insights and solutions for improving their gut health and alleviating digestive conditions like IBS. In Malaysia, approximately 14% of the population is affected by IBS, with many facin
- 김갑성 기자
- 2025-09-08 20:37
-
Medit Expands Orthodontic Suite with Launch of Medit Aligne…
NEWPORT BEACH, Calif., Sept. 8, 2025 -- Medit, a global leader in digital dentistry solutions, today announced the launch of Medit Aligners, a premium digital clear aligner solution designed to deliver faster turnaround times and more predictable outcomes for orthodontic patients. Medit Aligners integrate seamlessly with the Medit Orthodontic Suite (MOS), giving orthodontists the ability to simulate, design, and refine treatment plans before sending them directly into production. The result: a flexible, efficient workflow that combines clinical control with world-
- 김갑성 기자
- 2025-09-08 20:30
-
WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability…
SHANGHAI, Sept. 8, 2025 -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced it has received the Gold Medal by EcoVadis sustainability rating for the second consecutive year. This achievement reflects WuXi AppTec's commitment to sustainability and its ongoing efforts to integrate environmental and social responsibilities into the Company's business strategies and operations. EcoVadis is a leading sustainability rating agency for global supply chains.
- 김갑성 기자
- 2025-09-08 20:00
-
BrainCo Helps Amputee Showcase Technology at WAIC 2025
BOSTON, Sept. 8, 2025 -- At the 2025 World Artificial Intelligence Conference (WAIC) in August 2025, Gu demonstrated the BrainCo Intelligent Bionic Hand. He played the piano with precision and even explained to attendees how brain-computer interface (BCI) technology enables amputees to control prosthetic devices with their own neural signals. His presentation drew enthusiastic applause, offering the audience a vivid glimpse of how advanced technology is reshaping human potential. BrainCo, a global leader in non-invasive brain-computer interface (BCI) technology, continues to transform
- 김갑성 기자
- 2025-09-08 19:29
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-19_SUN
- Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting 15:00
- Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia 14:00
- From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use 13:00
- 내면의 조화를 발견하세요: '원더풀 인도네시아 웰니스 페스티벌 2025' 개최 01:50
- 제2회 마나르 아부다비 출품 작가 명단 공개 00:48
- 중국-피지 어업 협력, 섬나라 경제 활력 끌어올리다 00:00
2025-10-18_SAT
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 19일 16시 40분